| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.2M | -77.0% |
| SG&A Expense | $4.2M | -31.0% |
| Operating Income | -$5.8M | +49.0% |
| Pre-tax Income | -$6.2M | +50.7% |
| Income Tax | $6K | +232.2% |
| Net Income | -$6.3M | +53.3% |
| EPS (Basic) | -$17.55 | +86.7% |
| EPS (Diluted) | -$17.55 | +86.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.2M | +192.3% |
| Current Assets | $4.7M | +301.5% |
| Total Assets | $4.7M | +130.5% |
| Current Liabilities | $2.0M | -51.5% |
| Stockholders' Equity | $2.7M | +227.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.3M | +38.6% |
| Investing Cash Flow | -$1.9M | -145.2% |
| Financing Cash Flow | $9.0M | +1737.8% |